22157.jpg
Global Legionella Testing Market Report by Application, End User, and Region 2024-2032
16 mai 2024 10h16 HE | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Legionella Testing Market Report by Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.The...
22157.jpg
Legionella Testing Global Market Report 2024: Increasing Legionella Testing Demand From Hospitality Sector and Rising Incidence of Pneumonia and Legionella-related Illnesses
01 mai 2024 07h08 HE | Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Global Legionella Testing Market: Analysis By Type, By Application, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029" report...
2024 Albert B. Sabin Gold Medal awardees Dr. Keith Klugman (left) and Dr. Shabir Madhi (right), with 2024 Sabin Rising Star awardee Prof. Nicole Basta
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
19 avr. 2024 06h00 HE | Sabin Vaccine Institute
WASHINGTON, April 19, 2024 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and...
walgreens (Facebook Post)
Foundation for Sarcoidosis Research and Walgreens Unite in Alabama to Boost Sarcoidosis Awareness and Spring Vaccine Education for April Awareness Month
15 avr. 2024 18h31 HE | Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research Partners with Walgreens in Alabama to Raise Awareness for Sarcoidosis and Spring Vaccines
22157.jpg
Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024
15 mars 2024 05h28 HE | Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global acute...
22157.jpg
Respiratory Syncytial Virus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F
04 mars 2024 10h06 HE | Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
27 févr. 2024 15h52 HE | BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
22157.jpg
Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
20 déc. 2023 08h53 HE | Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Procalcitonin Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added to ResearchAndMarkets.com's...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Awarded $20 Million BARDA DRIVe Contract to Advance Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
16 oct. 2023 14h40 HE | BioAegis Therapeutics
Partnership supports execution of a large phase 2 global study to evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. NORTH BRUNSWICK, N.J., Oct....
ContraFect_LOGO_Web.jpg
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
16 oct. 2023 07h30 HE | ContraFect Corporation
YONKERS, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...